Based on the demonstrated anti-tumor activities, different mechanisms of action and toxicity profiles, we intended to study combinational therapeutic effect of CP and Mh in HepG2 cells and anticipated a synergistic interaction of CP-Mh combination. This evidence concerns the gene CP and neoplasm.